Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2024 »
Home
Forums
Diabetes Discussion
Insulin Pump Forum
NHS contract for an insulin pump
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="caius2x8" data-source="post: 2030833" data-attributes="member: 468721"><p>A</p><p></p><p></p><p>Agreed. Looking only at the clinical outcome is a narrow perspective. A patient moving from frequent borderline hypo to not hypo may have only imorived a little, but gained a lot in terms of social and professional functioning. From an economic perspective, clinical and broader perspectives are weighed up to inform policy. The national health regulator who review the cost-effectiveness of new treatments offer the guidance to ccgs and nhs trusts: </p><p></p><p>Recommendation: 1.1</p><p>"Continuous subcutaneous insulin infusion (CSII or 'insulin pump') therapy is recommended as a treatment option for adults and children 12 years and older with type 1 diabetes mellitus provided that:</p><p></p><p>attempts to achieve target haemoglobin A1c (HbA1c) levels with multiple daily injections (MDIs) result in the person experiencing disabling hypoglycaemia. For the purpose of this guidance, disabling hypoglycaemia is defined as the repeated and unpredictable occurrence of hypoglycaemia that results in persistent anxiety about recurrence and is associated with a significant adverse effect on quality of life</p><p></p><p>or</p><p></p><p>HbA1c levels have remained high (that is, at 8.5% [69 mmol/mol] or above) on MDI therapy (including, if appropriate, the use of long-acting insulin analogues) despite a high level of care."</p></blockquote><p></p>
[QUOTE="caius2x8, post: 2030833, member: 468721"] A Agreed. Looking only at the clinical outcome is a narrow perspective. A patient moving from frequent borderline hypo to not hypo may have only imorived a little, but gained a lot in terms of social and professional functioning. From an economic perspective, clinical and broader perspectives are weighed up to inform policy. The national health regulator who review the cost-effectiveness of new treatments offer the guidance to ccgs and nhs trusts: Recommendation: 1.1 "Continuous subcutaneous insulin infusion (CSII or 'insulin pump') therapy is recommended as a treatment option for adults and children 12 years and older with type 1 diabetes mellitus provided that: attempts to achieve target haemoglobin A1c (HbA1c) levels with multiple daily injections (MDIs) result in the person experiencing disabling hypoglycaemia. For the purpose of this guidance, disabling hypoglycaemia is defined as the repeated and unpredictable occurrence of hypoglycaemia that results in persistent anxiety about recurrence and is associated with a significant adverse effect on quality of life or HbA1c levels have remained high (that is, at 8.5% [69 mmol/mol] or above) on MDI therapy (including, if appropriate, the use of long-acting insulin analogues) despite a high level of care." [/QUOTE]
Verification
Post Reply
Home
Forums
Diabetes Discussion
Insulin Pump Forum
NHS contract for an insulin pump
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…